Six out of the 19 m6A regulators (ALKBH5, FMR1, HNRNPC, RBM15B, YTHDC2, and YTHDF1) showed statistically prognostic value in DLBCL patients (Figure 4(a)). This evidence concerns the gene YTHDF1 and diffuse large B-cell lymphoma.